|
| 36638628 | Generation of an induced pluripotent stem cell line CSSi015-A (9553), carrying a point mutation c.2915CÂ >Â T in the human calcium sensing receptor (CasR) gene. | Stem Cell Res | 2023 |
| 37598215 | APOGEE 2: multi-layer machine-learning model for the interpretable prediction of mitochondrial missense variants. | Nat Commun | 2023 |
| 38016468 | Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis. | Cell Stem Cell | 2023 |
| 37735434 | Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies. | J Exp Clin Cancer Res | 2023 |
| 37563568 | Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trial. | Mol Cancer | 2023 |
| 37025301 | Circadian profile, daytime activity, and the Parkinson's phenotype: A motion sensor pilot study with neurobiological underpinnings. | Neurobiol Sleep Circadian Rhythms | 2023 |
| 36819100 | Corrigendum: Deepening the understanding of CNVs on chromosome 15q11-13 by using hiPSCs: An overview. | Front Cell Dev Biol | 2023 |
| 36684422 | Deepening the understanding of CNVs on chromosome 15q11-13 by using hiPSCs: An overview. | Front Cell Dev Biol | 2023 |
| 34558001 | Culturing and Expansion of "Clinical Grade" Neural Stem Cells from the Fetal Human Central Nervous System. | Methods Mol Biol | 2022 |
| 35759972 | Generation of an induced pluripotent stem cells line, CSSi014-A 9407, carrying the variant c.479C>T in the human iduronate 2-sulfatase (hIDS) gene. | Stem Cell Res | 2022 |
| 35624679 | Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients. | Antioxidants (Basel) | 2022 |
| 35414102 | Growth factor independence underpins a paroxysmal, aggressive Wnt5a<sup>High</sup>/EphA2<sup>Low</sup> phenotype in glioblastoma stem cells, conducive to experimental combinatorial therapy. | J Exp Clin Cancer Res | 2022 |
| 36449945 | Determinants of success in treating acute ischemic cerebral and ocular ischemia through carotid revascularization. An observational study of a case series. | Rev Col Bras Cir | 2022 |
| 36411275 | Retinoic acid-induced 1 gene haploinsufficiency alters lipid metabolism and causes autophagy defects in Smith-Magenis syndrome. | Cell Death Dis | 2022 |
| 36071478 | AQP4-dependent glioma cell features affect the phenotype of surrounding cells via extracellular vesicles. | Cell Biosci | 2022 |
| 36040977 | Human neural stem cells drug product: Microsatellite instability analysis. | PLoS One | 2022 |
| 36362211 | Human Neural Stem Cell-Based Drug Product: Clinical and Nonclinical Characterization. | Int J Mol Sci | 2022 |
| 33300029 | MitImpact 3: modeling the residue interaction network of the Respiratory Chain subunits. | Nucleic Acids Res | 2021 |
| 33525510 | Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived Cells. | Int J Mol Sci | 2021 |
| 34944610 | COVID-19 Specific Immune Markers Revealed by Single Cell Phenotypic Profiling. | Biomedicines | 2021 |
| 34572266 | Storage of Mutant Human SOD1 in Non-Neural Cells from the Type-1 Amyotrophic Lateral Sclerosis rat<sup>G93A</sup> Model Correlated with the Lysosomes' Dysfunction. | Biomedicines | 2021 |
| 34351399 | A comparative benchmark of classic DNA motif discovery tools on synthetic data. | Brief Bioinform | 2021 |
| 34087986 | Generation of an induced pluripotent stem cell line (CSS012-A (7672)) carrying the p.G376D heterozygous mutation in the TARDBP protein. | Stem Cell Res | 2021 |
| 32182809 | A Link between Genetic Disorders and Cellular Impairment, Using Human Induced Pluripotent Stem Cells to Reveal the Functional Consequences of Copy Number Variations in the Central Nervous System-A Close Look at Chromosome 15. | Int J Mol Sci | 2020 |
| 33376983 | The adult human subventricular zone: partial ependymal coverage and proliferative capacity of cerebrospinal fluid. | Brain Commun | 2020 |
| 33317591 | BRAF<sup>V600E</sup> mutation impinges on gut microbial markers defining novel biomarkers for serrated colorectal cancer effective therapies. | J Exp Clin Cancer Res | 2020 |
| 32802275 | Mechanisms of pathogenesis of missense mutations on the KDM6A-H3 interaction in type 2 Kabuki Syndrome. | Comput Struct Biotechnol J | 2020 |
| 32739880 | Generation of an induced pluripotent stem cell line, CSSi011-A (6534), from an Amyotrophic lateral sclerosis patient with heterozygous L145F mutation in SOD1 gene. | Stem Cell Res | 2020 |
| 30324525 | Drug Delivery in an Orthotopic Tumor Stem Cell-Based Model of Human Glioblastoma. | Methods Mol Biol | 2019 |
| 31493762 | Generation of induced pluripotent stem cell line CSSi008-A (4698) from a patient affected by advanced stage of Dentato-Rubral-Pallidoluysian atrophy (DRPLA). | Stem Cell Res | 2019 |
| 31202121 | Production and characterization of human induced pluripotent stem cells (iPSC) CSSi007-A (4383) from Joubert Syndrome. | Stem Cell Res | 2019 |
| 31195749 | Parkin Mutation Affects Clock Gene-Dependent Energy Metabolism. | Int J Mol Sci | 2019 |
| 30923117 | Multifunctionalized hydrogels foster hNSC maturation in 3D cultures and neural regeneration in spinal cord injuries. | Proc Natl Acad Sci U S A | 2019 |
| 31056474 | Stemness underpinning all steps of human colorectal cancer defines the core of effective therapeutic strategies. | EBioMedicine | 2019 |
| 31024007 | Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats. | Cell Death Dis | 2019 |
| 30877104 | AQP4 Aggregation State Is a Determinant for Glioma Cell Fate. | Cancer Res | 2019 |
| 30718358 | Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma. | Cancer Res | 2019 |
| 31104357 | Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome. | Stem Cells Transl Med | 2019 |
| 29342448 | Generation of induced pluripotent stem cell line, CSSi002-A (2851), from a patient with juvenile Huntington Disease. | Stem Cell Res | 2018 |
| 30218896 | Copy number variations in healthy subjects. Case study: iPSC line CSSi005-A (3544) production from an individual with variation in 15q13.3 chromosome duplicating gene CHRNA7. | Stem Cell Res | 2018 |
| 30025485 | Advances in stem cell therapy for amyotrophic lateral sclerosis. | Expert Opin Biol Ther | 2018 |
| 30209666 | Human Fetal Neural Stem Cells for Neurodegenerative Disease Treatment. | Results Probl Cell Differ | 2018 |
| 29963265 | Cancer stem cells from peritumoral tissue of glioblastoma multiforme: the possible missing link between tumor development and progression. | Oncotarget | 2018 |
| 30224709 | Establishment of stable iPS-derived human neural stem cell lines suitable for cell therapies. | Cell Death Dis | 2018 |
| 30501625 | EphB2 stem-related and EphA2 progression-related miRNA-based networks in progressive stages of CRC evolution: clinical significance and potential miRNA drivers. | Mol Cancer | 2018 |
| 28334084 | Molecular dynamics recipes for genome research. | Brief Bioinform | 2018 |
| 29449625 | Toll-like receptor 4 modulation influences human neural stem cell proliferation and differentiation. | Cell Death Dis | 2018 |
| 29494847 | Production and characterization of CSSI003 (2961) human induced pluripotent stem cells (iPSCs) carrying a novel puntiform mutation in RAI1 gene, Causative of Smith-Magenis syndrome. | Stem Cell Res | 2018 |
| 29486399 | Generation of induced pluripotent stem cell line, CSSi004-A (2962), from a patient diagnosed with Huntington's disease at the presymptomatic stage. | Stem Cell Res | 2018 |
| 29704769 | Generation of the induced pluripotent stem cell line CSSi006-A (3681) from a patient affected by advanced-stage Juvenile Onset Huntington's Disease. | Stem Cell Res | 2018 |